HSBC Holdings’s Surmodics SRDX Stock Holding History

HSBC Holdings’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-299,165	Closed	-$9.01M	–	3146
2025 Q3	$9.01M	Buy	299,165 +32,369	+12%	+$1.08M	0.01%	963
2025 Q2	$8.01M	Sell	266,796 -246	-0.1%	-$7.09K	﹤0.01%	972
2025 Q1	$8.25M	Buy	267,042 +12,344	+5%	+$416K	0.01%	952
2024 Q4	$10.1M	Buy	254,698 +7,163	+3%	+$279K	0.01%	930
2024 Q3	$9.54M	Buy	+247,535	New	+$10M	0.01%	933
2022 Q2	–	Sell	-4,982	Closed	-$225K	–	3436
2022 Q1	$225K	Buy	+4,982	New	+$218K	﹤0.01%	2940
2018 Q4	–	Sell	-8,179	Closed	-$610K	–	2709
2018 Q3	$610K	Buy	+8,179	New	+$563K	﹤0.01%	1943

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HSBC Holdings's SRDX Position: Q4 2025 in Review

HSBC Holdings sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 299,165 shares — an estimated $9.01M sold.

HSBC Holdings first reported a position in SRDX in Q3 2018 and held it in 7 quarters. The position peaked at $10.1M in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

HSBC Holdings reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
HSBC Holdings sold 299,165 Surmodics shares in Q4 2025, an estimated $9.01M.
HSBC Holdings first reported a position in Surmodics in Q3 2018 and held it in 7 quarters.
HSBC Holdings's Surmodics position peaked at $10.1M in Q4 2024.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on HSBC Holdings's 13F filing for Q4 2025, filed 6 Mar 2026.